Evaluating HER2 amplification status and acquired drug resistance in breast cancer cells using Raman spectroscopy.

Bi X, Rexer B, Arteaga CL, Guo M, Mahadevan-Jansen A
J Biomed Opt. 2014 19 (2): 025001

PMID: 24496495 · PMCID: PMC3913568 · DOI:10.1117/1.JBO.19.2.025001

MeSH Terms (9)

Breast Neoplasms Cell Line, Tumor Drug Resistance, Neoplasm Female Humans Lapatinib Quinazolines Receptor, ErbB-2 Spectrum Analysis, Raman

Connections (3)

This publication is referenced by other Labnodes entities:

Links